Traws Pharma, Inc.

New Filing

CIK: 0001130598·Biotechnology·DELAWARE·Filed: Nov 5, 2026

Total Offering

$50,000,000

Amount Sold

$0

Investors

1

First Sale

N/A

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Iain Dukes	Related Person
Charles Parker	Related Person
Jack E. Stover	Related Person
Nikolay Savchuk	Related Person
Trafford Clarke	Related Person
Mary Teresa Shoemaker	Related Person
John Leaman	Related Person
Werner Cautreels	Related Person

Company

Traws Pharma, Inc.

12 PENNS TRAIL

NEWTOWN, PA, 18940

267-759-3680

SEC Filing

0001130598-26-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.